Comparative stemness and differentiation of luminal and basal breast cancer stem cell type under...

Area of Science:

• Oncology
• Cell Biology
• Metabolic Pathways

Background:

• Glutamine metabolism is a key target in cancer therapy.
• The impact of glutamine deprivation on breast cancer stem cells (bCSCs) is not well understood.
• Understanding bCSC behavior is crucial for effective breast cancer treatment.

Purpose of the Study:

• To investigate the effect of glutamine deprivation on the stemness and differentiation of bCSCs.
• To analyze changes in epithelial and mesenchymal markers in response to glutamine levels.
• To explore the role of beta-catenin in glutamine-deprived bCSCs.

Main Methods:

• Isolation and culture of bCSCs from MCF-7 and MDAMB-231 cell lines.
• Assessment of cell differentiation using markers like CD24, EpCAM, and CD44.
• Analysis of gene expression for stemness markers (Sox-2, Oct-4, Nanog) and epithelial/mesenchymal markers (e-cadherin, n-cadherin).
• Evaluation of beta-catenin localization using cellular imaging techniques.

Main Results:

• Glutamine deprivation induced bCSC differentiation into CD24+ epithelial cells.
• Epithelial markers (e-cadherin, claudin-1) increased, while mesenchymal marker (n-cadherin) decreased.
• Stemness markers (Sox-2, Oct-4, Nanog) significantly decreased in MDAMB-231 bCSCs.
• Beta-catenin accumulated in the cytosol/perinuclear space, hindering gene transcription.

Conclusions:

• Glutamine deprivation promotes bCSC differentiation into epithelial subtypes and reduces stemness.
• Reduced nuclear localization of beta-catenin mediates the observed effects.
• Basal and luminal bCSCs exhibit differential responses to glutamine availability.
• Findings suggest potential modifications to glutamine-targeting regimens for breast cancer therapy.